{"id":"https://openalex.org/W4384299136","doi":"https://doi.org/10.1158/1078-0432.23683825","title":"Supplementary Table S2 from Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia","display_name":"Supplementary Table S2 from Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia","publication_year":2023,"publication_date":"2023-07-14","ids":{"openalex":"https://openalex.org/W4384299136","doi":"https://doi.org/10.1158/1078-0432.23683825"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.23683825","doi":"https://doi.org/10.1158/1078-0432.23683825","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.23683825","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.23683825","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026842309","display_name":"John Nathan Allan","orcid":"https://orcid.org/0000-0002-2088-0899","observed_orcids":["https://orcid.org/0000-0002-2088-0899"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John N. Allan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2088-0899","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000959540","display_name":"Ian W. Flinn","orcid":"https://orcid.org/0000-0001-6724-290X","observed_orcids":["https://orcid.org/0000-0001-6724-290X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ian W. Flinn","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6724-290X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005565037","display_name":"Tanya Siddiqi","orcid":"https://orcid.org/0000-0001-5292-8298","observed_orcids":["https://orcid.org/0000-0001-5292-8298"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tanya Siddiqi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5292-8298","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087770514","display_name":"Paolo Ghia","orcid":"https://orcid.org/0000-0003-3750-7342","observed_orcids":["https://orcid.org/0000-0003-3750-7342"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paolo Ghia","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3750-7342","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034517642","display_name":"Constantine Si Lun Tam","orcid":"https://orcid.org/0000-0002-9759-5017","observed_orcids":["https://orcid.org/0000-0002-9759-5017"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Constantine S. Tam","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9759-5017","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036828560","display_name":"Thomas J. Kipps","orcid":"https://orcid.org/0000-0002-0064-4549","observed_orcids":["https://orcid.org/0000-0002-0064-4549"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas J. Kipps","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0064-4549","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055100327","display_name":"Paul M. Barr","orcid":"https://orcid.org/0000-0002-9733-401X","observed_orcids":["https://orcid.org/0000-0002-9733-401X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul M. Barr","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9733-401X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078620979","display_name":"Anna Elinder Camburn","orcid":"https://orcid.org/0000-0002-6097-7839","observed_orcids":["https://orcid.org/0000-0002-6097-7839"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Elinder Camburn","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6097-7839","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008054206","display_name":"Alessandra Tedeschi","orcid":"https://orcid.org/0000-0001-8724-2771","observed_orcids":["https://orcid.org/0000-0001-8724-2771"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alessandra Tedeschi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8724-2771","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085393928","display_name":"Xavier Camille Albert Badoux","orcid":"https://orcid.org/0000-0001-9042-527X","observed_orcids":["https://orcid.org/0000-0001-9042-527X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xavier C. Badoux","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9042-527X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035890812","display_name":"Ryan W. Jacobs","orcid":"https://orcid.org/0000-0001-7814-7959","observed_orcids":["https://orcid.org/0000-0001-7814-7959"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryan Jacobs","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7814-7959","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002467749","display_name":"Bryone Jean Kuss","orcid":"https://orcid.org/0000-0002-5811-1331","observed_orcids":["https://orcid.org/0000-0002-5811-1331"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bryone J. Kuss","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5811-1331","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013236194","display_name":"Livio Trentin","orcid":"https://orcid.org/0000-0003-1222-6149","observed_orcids":["https://orcid.org/0000-0003-1222-6149"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Livio Trentin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1222-6149","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053787554","display_name":"Cathy Zhou","orcid":"https://orcid.org/0000-0003-2406-1484","observed_orcids":["https://orcid.org/0000-0003-2406-1484"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cathy Zhou","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2406-1484","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109542836","display_name":"Anita Sz\u0151ke","orcid":"https://orcid.org/0000-0001-6975-7114","observed_orcids":["https://orcid.org/0000-0001-6975-7114"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anita Szoke","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6975-7114","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092111581","display_name":"Christopher Abbazio","orcid":"https://orcid.org/0000-0002-1917-7290","observed_orcids":["https://orcid.org/0000-0002-1917-7290"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher Abbazio","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1917-7290","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5089428686","display_name":"William G. Wierda","orcid":"https://orcid.org/0000-0002-7357-270X","observed_orcids":["https://orcid.org/0000-0002-7357-270X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William G. Wierda","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7357-270X","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9789999723434448},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":1.0},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9580000042915344},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8389999866485596},{"id":"https://openalex.org/keywords/high-risk-features","display_name":"high-risk features","score":0.9470000267028809},{"id":"https://openalex.org/keywords/sensitivity-analysis","display_name":"sensitivity analysis","score":0.7519999742507935},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.7599999904632568},{"id":"https://openalex.org/keywords/treatment-outcomes","display_name":"treatment outcomes","score":0.38100001215934753}],"concepts":[{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.8646787405014038},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.7648096084594727},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6182131171226501},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6008644104003906},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.5967900156974792},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5095465779304504},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4970686733722687},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49463316798210144},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3274095058441162},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08510527014732361},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.23683825","doi":"https://doi.org/10.1158/1078-0432.23683825","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.23683825","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.23683825.v1","doi":"https://doi.org/10.1158/1078-0432.23683825.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.23683825.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/23683825","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Outcomes_in_Patients_with_High-Risk_Features_after_Fixed-Duration_Ibrutinib_plus_Venetoclax_Phase_II_CAPTIVATE_Study_in_First-Line_Chronic_Lymphocytic_Leukemia/23683825","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.23683825","doi":"https://doi.org/10.1158/1078-0432.23683825","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.23683825","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4379598412","https://openalex.org/W4384300296","https://openalex.org/W4400109298","https://openalex.org/W4379768976","https://openalex.org/W4401878482","https://openalex.org/W4282964256","https://openalex.org/W4401876857","https://openalex.org/W4385628205","https://openalex.org/W4380085383","https://openalex.org/W4379281324"],"abstract_inverted_index":{"Supplementary":[0],"Table":[1],"S2.":[2],"Sensitivity":[3],"analysis":[4],"of":[5],"outcomes":[6],"in":[7],"patients":[8,15],"with":[9],"versus":[10],"without":[11],"high-risk":[12],"features,":[13],"excluding":[14],"from":[16],"the":[17],"CAPTIVATE":[18],"MRD":[19],"cohort":[20],"placebo":[21],"arm":[22]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-07-15T00:00:00"}